Near-term, we have the potential to transform the treatment of thalassemia and sickle cell disease with PYRUKYND. And beyond, we have the opportunity to deliver additional medicines to rare disease ...
Sign up for The Media Today, CJR’s daily newsletter. We are, apparently, a nation whose Army marches on PowerPoint. As detailed in Elisabeth Bumiller’s Tuesday ...
Next slide, please. Our strong balance sheet supports our focused capital allocation strategy, allowing us to invest in our next wave of growth and pipeline delivery. First, we have executed a capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results